| 中國醫藥大學 |
2011-02 |
Prognostic Factors in Patients with Buccal Squamous Cell Carcinoma: Ten-year Experience
|
詹日全(Jih-Chuan Jan); 徐武輝(Wu-Huei Hsu)*; 劉時安(Shih-An Liu); 黃穰基(Yong-Kie Wong); 潘超群(Chiu-Kwan Poon); 江榮山(Rong-San Jiang); 詹建勝(Jian-Sheng Jan); 陳依凡(I-Fan Chen) |
| 嘉南藥理大學 |
2016-09 |
Prognostic Factors in Patients With Pulmonary Hypertension-A Nationwide Cohort Study
|
Chang, Wei-Ting; Weng, Shih-Feng; Hsu, Chih-Hsin; Shih, Jhih-Yuan; Wang, Jhi-Joung; Wu, Chun-Ying; Chen, Zhih-Cherng |
| 臺北醫學大學 |
2004 |
Prognostic factors in phyllodes tumor of the breast: Are immuohistochemical biomarkers useful?
|
朱娟秀; Chu JS |
| 國立臺灣大學 |
2015 |
Prognostic factors in Taiwanese patients with penile-invasive squamous cell carcinoma
|
Geng, Jiun-Hung; Huang, Shu-Pin; Huang, Chao-Yuan; 黃昭淵 |
| 臺大學術典藏 |
2021-10-14T02:45:50Z |
Prognostic factors in Taiwanese patients with penile-invasive squamous cell carcinoma
|
Geng J.-H.; Huang S.-P.; CHAO-YUAN HUANG |
| 高雄醫學大學 |
2002 |
Prognostic Factors in the Treatment of Osteosarcoma -- Review of 65 Cases in Recent 10 years
|
方璟文;簡松雄;林高田;林森源 |
| 國立臺灣大學 |
2009 |
Prognostic Factors in Women with Early Stage Small Cell Carcinoma of the Uterine Cervix
|
黃昭源; 陳宇立; 朱鐵吉; 鄭文芳; 謝長堯; 林明杰; HUANG, CHAO-YUAN; CHEN, YU-LI; CHU, TIEH-CHI; CHENG, WEN-FANG; HSIEH, CHANG-YAO; LIN, MING-CHIEH |
| 臺大學術典藏 |
2020-02-06T05:22:16Z |
Prognostic factors in women with early stage small cell carcinoma of the uterine cervix
|
Lin M.-C.;Hsieh C.-Y.;WEN-FANG CHENG;Chu T.-C.;Chen Y.-L.;Huang C.-Y.; Huang C.-Y.; Chen Y.-L.; Chu T.-C.; WEN-FANG CHENG; Hsieh C.-Y.; Lin M.-C.; Huang C.-Y.; Chen Y.-L.; Chu T.-C.; WEN-FANG CHENG; Hsieh C.-Y.; Lin M.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:01Z |
Prognostic factors in women with early stage small cell carcinoma of the uterine cervix
|
Huang C.-Y.; Chen Y.-L.; Chu T.-C.; WEN-FANG CHENG; Hsieh C.-Y.; Lin M.-C. |
| 臺大學術典藏 |
2020-05-24T06:00:24Z |
Prognostic factors in women with early stage small cell carcinoma of the uterine cervix
|
Huang C.-Y.; YU-LI CHEN; Chu T.-C.; Cheng W.-F.; Hsieh C.-Y.; Lin M.-C. |
| 臺大學術典藏 |
2020-11-27T08:14:21Z |
Prognostic factors in women with early stage small cell carcinoma of the uterine cervix
|
Huang C.-Y.; Chen Y.-L.; Chu T.-C.; Cheng W.-F.; CHANG-YAO HSIEH; Lin M.-C. |
| 臺大學術典藏 |
2021-10-14T02:46:07Z |
Prognostic factors in women with early stage small cell carcinoma of the uterine cervix
|
CHAO-YUAN HUANG; Chen Y.-L.; Chu T.-C.; Cheng W.-F.; Hsieh C.-Y.; Lin M.-C. |
| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Wei-Yu Liao;Ho C.-C.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; WEI-YU LIAO; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:18Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Ko J.-C.; Shih J.-Y.; Liang S.-K.; Lee M.-R.; Liao W.-Y.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-08-13T06:33:31Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Ko J.-C.;Jin-Yuan Shih; Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-12T02:50:39Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Shih J.-Y.; Ko J.-C.; CHAO-CHI HO; Liang S.-K.;Lee M.-R.;Liao W.-Y.;Chao-Chi Ho;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; Liao W.-Y. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Shih J.-Y.; Ko J.-C.; Ho C.-C.; Liao W.-Y.; Lee M.-R.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-03-11T07:58:28Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:34:19Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T02:50:57Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-17T03:21:18Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
SHENG-KAI LIANG; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-10-04T07:15:41Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2018 |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liao W.-Y.; MENG-RUI LEE; Liang S.-K.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
